In the latest trading session,, 0.57 million Macrogenics Inc (NASDAQ:MGNX) shares changed hands as the company’s beta touched 2.19. With the company’s most recent per share price at $14.07 changed hands at -$1.98 or -12.34% at last look, the market valuation stands at $880.22M. MGNX’s current price is a discount, trading about -55.51% off its 52-week high of $21.88. The share price had its 52-week low at $4.29, which suggests the last value was 69.51% up since then. When we look at Macrogenics Inc’s average trading volume, we note the 3-month average coming to 1.43 million.
Macrogenics Inc (NASDAQ:MGNX) trade information
Instantly MGNX was in red as seen in intraday trades today. With action -9.52%, the performance over the past five days has been red. The drop to weekly highs of 16.44 subtracted -12.34% to the stock’s daily price. The company’s shares are showing year-to-date upside of 46.26%, with the 5-day performance at -9.52% in the red. However, in the 30-day time frame, Macrogenics Inc (NASDAQ:MGNX) is -22.27% down.
Macrogenics Inc (MGNX) estimates and forecasts
Data shows that the Macrogenics Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 158.64% over the past 6 months, a -34.13% in annual growth rate that is considerably lower than the industry average of 17.70%. Year-over-year growth is forecast to reach 17.10% up from the last financial year.
Consensus estimates given by 11 financial analysts project the company’s revenue in the current quarter to hit an average of 14.62M. 10 analysts are of the opinion that Macrogenics Inc’s revenue for the current quarter will be 16.71M. The company’s revenue for the corresponding quarters a year ago was 24.5M. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -40.30%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 48.88%. The 2024 estimates are for Macrogenics Inc earnings to decrease by -1616.51%.
